Alkeus Pharmaceuticals, Inc.

About Alkeus Pharmaceuticals, Inc.

Alkeus Pharmaceuticals, Inc. is dedicated to preserving the sight of individuals impacted by retinal disease through breakthrough scientific advancements. Their mission focuses on addressing urgent unmet needs in retinal disease treatment, particularly for conditions like Stargardt disease and geographic atrophy secondary to age-related macular degeneration.

Products & Services

Gildeuretinol Acetate:An oral investigational therapy designed to reduce vitamin A dimerization in the retina without modulating the visual cycle, targeting Stargardt disease and geographic atrophy.

Specialties

Retinal disease treatment Stargardt disease therapy Geographic atrophy therapy Investigational oral therapies

Funding History

No funding data available

This company may be bootstrapped or privately funded

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

David Arkowitz

Chief Financial Officer

M

Michel Dahan

President and Chief Executive Officer

T

Tamara Dillon

Chief Human Resources Officer

S

Srinivas Duggirala

Senior Vice President, Technical Operations

S

Seemi Khan

Chief Medical Officer

D

David Setboun

Chief Operating Officer

View 14 more team members with Pro

Unlock Full Team Directory

Recent News